Skip to content
Disclosery

New Leaf Venture Partners, L.L.C.

Follow

13F filer, CIK 1631614, New York, NY

New Leaf Venture Partners, L.L.C. reported $82,237,627 across 10 holdings for the quarter ended 2024-06-30, in a 13F-HR filed 2024-08-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-24-008255

Period
2024-06-30
Reported value
$82.2M
Holdings
10
Top 10 weight
100%
New
0
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
RCKTadded+32,464$699K
ITRMFadded+2$2

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
DECIPHERA PHARMACEUTICALS INexited-576,975-$9.08M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2024

Share positions as resolved from 13F-HR 0000950123-24-008255, largest first. % of portfolio is the value over $82,237,627, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ARVNARVINAS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 1,289,521 shares; 2024Q1: 1,289,521 shares; 2024Q2: 1,289,521 shares 1,289,521$34.3M41.74%0Timeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 1,553,661 shares; 2024Q1: 1,553,661 shares; 2024Q2: 1,553,661 shares 1,553,661$28M34.03%0Timeline
CRNXCRINETICS PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 141,000 shares; 2024Q1: 141,000 shares; 2024Q2: 141,000 shares 141,000$6.32M7.68%0Timeline
RALLYBIO CORPRALLYBIO CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 3,301,603 shares; 2024Q1: 3,301,603 shares; 2024Q2: 3,301,603 shares 3,301,603$4.42M5.38%0
RCKTROCKET PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 118,242 shares; 2024Q1: 118,242 shares; 2024Q2: 150,706 shares 150,706$3.24M3.95%+32,464Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 250,765 shares; 2024Q1: 250,765 shares; 2024Q2: 250,765 shares 250,765$2.11M2.57%0Timeline
PASSAGE BIO INCPASSAGE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 2,497,922 shares; 2024Q1: 2,497,922 shares; 2024Q2: 2,497,922 shares 2,497,922$1.98M2.41%0
ALECALECTOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 339,569 shares; 2024Q1: 339,569 shares; 2024Q2: 339,569 shares 339,569$1.54M1.87%0Timeline
X4 PHARMACEUTICALS INCX4 PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 335,000 shares; 2024Q1: 335,000 shares; 2024Q2: 335,000 shares 335,000$194K0.24%0
ITRMFITERUM THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 97,084 shares; 2024Q1: 97,084 shares; 2024Q2: 97,086 shares 97,086$111K0.14%+2Timeline

Sold out in Q2 2024

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
DECIPHERA PHARMACEUTICALS INDECIPHERA PHARMACEUTICALS IN576,975$9.08Mshares

How Q2 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-24-008255 base2024-08-14acceptance time not in the bulk data set